Arnim Helmboldt
Keine laufenden Positionen mehr
Profil
Arnim Helmboldt has been Head of Vice President of Sales and Marketing for SynphaBase AG since 2008.
He held several sales and marketing positions at Ciba, Inc. from 1997 to 2008.
Dr. Helmboldt received degrees from the University of Pavia and the Ecole National Supérieure de Chimie de Montpellier and a PhD from the École Normale Supérieure.
Ehemalige bekannte Positionen von Arnim Helmboldt
| Unternehmen | Position | Ende |
|---|---|---|
SynphaBase AG
 SynphaBase AG Miscellaneous Commercial ServicesCommercial Services SynphaBase AG provides contract research and development services to the pharmaceutical and chemical industry. Its products and services include route finding and process development, production of multi-kg up to metric tons, lab scale synthesis and carbohydrates and glycans. The firm’s catalogue includes monosaccharides as building blocks for glycan synthesis with various protecting group patterns and linker systems, disaccharides, oligosaccharides, glycosyl amino acids; core structures and building blocks for carbohydrate-based vaccine. The company was founded by in Arthur Bodenmüller in December 2000 and is headquartered in Pratteln, Switzerland. | Vertrieb & Marketing | - |
Ausbildung von Arnim Helmboldt
| Ecole Nationale Supérieure de Chimie de Montpellier | Graduate Degree |
| University of Pavia | Undergraduate Degree |
| École Normale Supérieure | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
SynphaBase AG
SynphaBase AG Miscellaneous Commercial ServicesCommercial Services SynphaBase AG provides contract research and development services to the pharmaceutical and chemical industry. Its products and services include route finding and process development, production of multi-kg up to metric tons, lab scale synthesis and carbohydrates and glycans. The firm’s catalogue includes monosaccharides as building blocks for glycan synthesis with various protecting group patterns and linker systems, disaccharides, oligosaccharides, glycosyl amino acids; core structures and building blocks for carbohydrate-based vaccine. The company was founded by in Arthur Bodenmüller in December 2000 and is headquartered in Pratteln, Switzerland. | Commercial Services |
